Asano Y - Search Results

1

Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S. Yanaba K, et al. Among authors: asano y. Clin Rheumatol. 2011 Jun;30(6):825-30. doi: 10.1007/s10067-011-1686-5. Epub 2011 Jan 19. Clin Rheumatol. 2011. PMID: 21246230

2

The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.

Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Asano Y, et al. J Invest Dermatol. 2003 Feb;120(2):204-10. doi: 10.1046/j.1523-1747.2003.12028.x. J Invest Dermatol. 2003. PMID: 12542523

3

Elevated serum levels of manganese superoxide dismutase in patients with eosinophilic fasciitis.

Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Among authors: asano y. Clin Rheumatol. 2003 Dec;22(6):505. doi: 10.1007/s10067-003-0781-7. Epub 2003 Sep 30. Clin Rheumatol. 2003. PMID: 14677046 No abstract available.

4

Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts.

Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Asano Y, et al. J Clin Invest. 2004 Jan;113(2):253-64. doi: 10.1172/JCI16269. J Clin Invest. 2004. PMID: 14722617 Free PMC article.

5

Serum matrix metalloproteinase-3 in systemic sclerosis.

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Jinnin M, et al. Among authors: asano y. Arch Dermatol Res. 2004 Jun;296(1):25-9. doi: 10.1007/s00403-004-0468-1. Epub 2004 Apr 17. Arch Dermatol Res. 2004. PMID: 15095096

6

Serum levels of manganese superoxide dismutase in patients with localized scleroderma.

Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Among authors: asano y. Exp Dermatol. 2004 Jun;13(6):357-60. doi: 10.1111/j.0906-6705.2004.00160.x. Exp Dermatol. 2004. PMID: 15186321

7

Clinical and laboratory features of scleroderma patients developing skeletal myopathy.

Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Mimura Y, et al. Among authors: asano y. Clin Rheumatol. 2005 Apr;24(2):99-102. doi: 10.1007/s10067-004-0975-7. Epub 2004 Aug 20. Clin Rheumatol. 2005. PMID: 15322944

8

Regulation of fibrogenic/fibrolytic genes by platelet-derived growth factor C, a novel growth factor, in human dermal fibroblasts.

Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Among authors: asano y. J Cell Physiol. 2005 Feb;202(2):510-7. doi: 10.1002/jcp.20154. J Cell Physiol. 2005. PMID: 15389578

9

Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.

Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Asano Y, et al. Arthritis Rheum. 2005 Apr;52(4):1237-47. doi: 10.1002/art.20934. Arthritis Rheum. 2005. PMID: 15818662

10

Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.

Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Tamaki K. Mimura Y, et al. Among authors: asano y. Am J Pathol. 2005 May;166(5):1451-63. doi: 10.1016/s0002-9440(10)62362-0. Am J Pathol. 2005. PMID: 15855645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results